TickerFactsScreenerDevelopers

DiaMedica Therapeutics Inc. (DMAC) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: $1.11M2017: $799.0K2018: $17.02M2019: $7.62M2020: $26.01M2021: $44.02M2022: $31.83M2023: $51.06M2024: $40.72M2025: $56.11M$56.11M
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$56.11M+37.8%
2024$40.72M-20.2%
2023$51.06M+60.4%
2022$31.83M-27.7%
2021$44.02M+69.2%
2020$26.01M+241.5%
2019$7.62M-55.3%
2018$17.02M+2030.8%
2017$799.0K-28.1%
2016$1.11M—